In Brief Blue Cross & Blue Shield of Minnesota and Minnesota Oncology announce five-year collaboration September 06, 2019Vol.45 No.33
NCI Lowy: NCI needs 15% budget increase to reach FY2021 goal of 15th percentile for paylines September 06, 2019Vol.45 No.33By Matthew Bin Han Ong
Drugs & Targets FDA approves darolutamide for non-metastatic castration-resistant prostate cancer August 02, 2019Vol.45 No.31
Drugs & Targets FDA grants breakthrough designation for NKTR-214 in combination with nivolumab for melanoma August 02, 2019Vol.45 No.31
Drugs & Targets EMA adopts positive opinion for Keytruda + Inlyta as first-line for RCC August 02, 2019Vol.45 No.31
Trials & Tribulations Barriers to clinical trial enrollmentPart I of a two-part series August 02, 2019Vol.45 No.31By Daniel Wall, Stephanie Engelien and Adedayo A. Onitilo
In Brief ACS CAN report: Texas must improve cancer-related public policies August 02, 2019Vol.45 No.31
